Evaluation of the first potent and highly selective inhibitor of ATR kinase: An approach to selectively sensitize cancer cells to ionizing radiation and hypoxia

被引：0
|
作者：
McKenna, Gillies [1 ]
Brunner, Thomas [1 ]
Charlton, Peter [2 ]
Fokas, Emmanouil [1 ]
Hammond, Ester [1 ]
Mangan, Matthew [2 ]
Olcina, Monica [1 ]
Pires, Isabel [1 ]
Pollard, John [2 ]
Prevo, Remko [1 ]
Reaper, Philip [2 ]
机构：
[1] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England
[2] Vertex Pharmaceut Europe Ltd, Abingdon, Oxon, England
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5501
引用
收藏
页数：1
相关论文
共 48 条
  • [31] FIRST-IN-HUMAN EVALUATION OF CO-1686, AN IRREVERSIBLE, HIGHLY SELECTIVE TYROSINE KINASE INHIBITOR OF MUTATIONS OF EGFR (ACTIVATING AND T790M)
    Wakelee, H.
    Soria, J.
    Camidge, R.
    Gadgeel, S.
    Goldman, J.
    Varga, A.
    Solomon, B.
    Papadimitrakopoulou, V.
    Kaur, P.
    Sequist, L. V.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S38 - S38
  • [32] First-in-human Safety, Pharmacokinetics and Pharmacodynamics of THB001: An Orally Available, Potent and Highly Selective Small Molecule Inhibitor of Wild Type KIT Receptor Tyrosine Kinase
    Sweeney, Steven
    Voors-Pette, Christine
    Nijhuis, Jerome Oude
    Keaney, Gregg
    Parry, Graham
    Conner, Edward
    Nix, Darrell
    Rioux, Nathalie
    DiRico, Amy
    Yoo, Stephen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB51 - AB51
  • [33] Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells
    Tao, Y.
    Zhang, P.
    Frascogna, V.
    Lecluse, Y.
    Auperin, A.
    Bourhis, J.
    Deutsch, E.
    BRITISH JOURNAL OF CANCER, 2007, 97 (12) : 1664 - 1672
  • [34] Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells
    Y Tao
    P Zhang
    V Frascogna
    Y Lecluse
    A Auperin
    J Bourhis
    E Deutsch
    British Journal of Cancer, 2007, 97 : 1664 - 1672
  • [35] The selective Aurora-A kinase inhibitor MLN8237 (alisertib) potently inhibits proliferation of glioblastoma neurosphere tumor stem-like cells and potentiates the effects of temozolomide and ionizing radiation
    Hong, Xin
    O'Donnell, James P.
    Salazar, Clarence R.
    Van Brocklyn, James R.
    Barnett, Kahlil D.
    Pearl, Dennis K.
    deCarvalho, Ana C.
    Ecsedy, Jeffrey A.
    Brown, Stephen L.
    Mikkelsen, Tom
    Lehman, Norman L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 983 - 990
  • [36] Identification and preclinical characterization of CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase, in lymphoma and non-small cell lung cancer models
    Cheng, Mangeng
    Quail, Matthew R.
    Gingrich, Diane E.
    Ott, Gregory R.
    Lu, Lihui
    Wan, Weihua
    Albom, Mark S.
    Angeles, Thelma S.
    Aimone, Lisa D.
    Cristofani, Flavio
    Machiorlatti, Rodolfo
    Abele, Cristina
    Ator, Mark A.
    Dorsey, Bruce D.
    Inghirami, Giorgio
    Ruggeri, Bruce A.
    CANCER RESEARCH, 2011, 71
  • [37] The selective Aurora-A kinase inhibitor MLN8237 (alisertib) potently inhibits proliferation of glioblastoma neurosphere tumor stem-like cells and potentiates the effects of temozolomide and ionizing radiation
    Xin Hong
    James P. O’Donnell
    Clarence R. Salazar
    James R. Van Brocklyn
    Kahlil D. Barnett
    Dennis K. Pearl
    Ana C. deCarvalho
    Jeffrey A. Ecsedy
    Stephen L. Brown
    Tom Mikkelsen
    Norman L. Lehman
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 983 - 990
  • [38] Contribution of RIPK1 kinase activity to cell death induced by anti-cancer agents using 7-CI-O-Nec-1, a potent and highly selective RIPK1 kinase inhibitor
    Alavi, Alireza
    Benetatos, Christopher
    Yuan, Junying
    Degterev, Alexei
    Franklin, Jessica
    Condon, Stephen
    McKinlay, Mark
    Chunduru, Srinivas
    CANCER RESEARCH, 2009, 69
  • [39] Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3
    Kim, Byeong Mo
    Won, Juyoon
    Maeng, Kyung Ah
    Han, Young Soo
    Yun, Yeon-Sook
    Hong, Sung Hee
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (05) : 1467 - 1473
  • [40] First-in-human (FIH) study of SCC244, a novel potent and highly selective c- MET inhibitor, in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Chen, H-J.
    Yang, J-J.
    Zhou, J-Y.
    Zhao, J.
    Sun, Y-P.
    Wen, Q.
    Zhou, Q.
    Zhang, Z.
    Tu, H-Y.
    Zhou, J-Y.
    Zhang, P.
    Chen, X.
    Chen, H-X.
    Dang, Q.
    Sun, M-H.
    Li, Y.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2021, 32 : S14 - S14
12345